ABVC BioPharma Receives Australian TGA Approval to Initiate Phase II Study of…
<!-- Name:DistributionId Value:8753201 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
ABVC BioPharma
ABVC Notes New Report That Estimates Global Retinal Surgical Instruments Market to…
-- Growth to benefit ABVC’s Vitargus medical device product -- FREMONT, CA, July 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage…
Central IRB Approved for ABV-1505 Phase II Part II in Taiwan Sites
ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study Completion of the Study Expected by the End of 2022 FREMONT, CA, Oct. 27, 2021…